Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (18) Bunse, Mario Dr. (1) Daniel, Peter Prof. Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Willimsky, Gerald Dr. (2) (-) Kammertöns, Thomas Dr. (6) (-) Nguyen, Tam Hoai Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (5) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (2) Epigenetische Regulation und Chromatinstruktur (10) Intrazelluläre Proteolyse (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (10) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (1) 1998 (1) 1999 (1) 2000 (3) 2001 (1) 2003 (5) (-) 2004 (5) 2005 (5) 2006 (1) (-) 2007 (2) 2008 (1) 2009 (3) 2010 (2) (-) 2011 (3) 2012 (3) 2013 (4) 2014 (1) 2015 (3) 2016 (2) 2017 (1) 2018 (2) 2019 (2) 2020 (3) 2022 (2) 2023 (1) 10 Ergebnisse: Active Filter: Kammertöns, Thomas Dr.Nguyen, Tam Hoai Dr.Uckert, Wolfgang Prof. Dr.Molekulare Immunologie und Gentherapie 200420072011 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. Januar 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. Januar 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 01. November 2007 / J Allergy Clin Immunol Neuroimmune crosstalk in asthma: dual role of the neurotrophin receptor p75NTR C. Nassenstein T. Kammertoens T.Z. Veres W. Uckert E. Spies B. Fuchs N. Krug A. Braun 15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein
01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. Januar 2004 / Blood Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets M. Stelljes R. Strothotte H.G. Pauels C. Poremba M. Milse C. Specht J. Albring G. Bisping C. Scheffold T. Kammertoens E. Oelmann G. Silling W.E. Berdel J. Kienast
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. Januar 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
01. November 2007 / J Allergy Clin Immunol Neuroimmune crosstalk in asthma: dual role of the neurotrophin receptor p75NTR C. Nassenstein T. Kammertoens T.Z. Veres W. Uckert E. Spies B. Fuchs N. Krug A. Braun
15. Oktober 2007 / J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein